Kodama I, Aoyagi K, Tanaka T, Kumegawa H, Ohta J, Maruiwa M, Kofuji K, Takeda J, Kakegawa T
First Dept. of Surgery, Kurume University School of Medicine.
Gan To Kagaku Ryoho. 1993 Jul;20(9):1237-40.
A sixty-eight-year-old male patient was diagnosed as having inoperable advanced gastric cancer with liver and lung metastasis. The patient was treated by combined chemo-immunotherapy of MMC 10 mg/M, 5'-DFUR 800 mg/day and OK-432 5 KE/2 W. Six months after commencing chemotherapy, CT-scan and upper GI series revealed that metasized liver tumors and stomach lesion were remarkably decreased in size and no cancer cell was confirmed by endoscopic biopsy. Further, the metastatic lung tumor has disappeared on chest X-ray. The patient had been well without any evidence of tumor re-progression for over one year, but from July the liver tumor began to metastasize again and the patient eventually died of liver metastasis on Jan. 1, 1993.
